{"entity":{"type":"insider","cik":"0001604072","url":"/insider/0001604072","json_url":"/insider/0001604072.json","name":"Ventech Capital II","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":5,"first":"2014-05-08","last":"2017-03-21","span_basis":"filed_date"},"name_variants":[{"name":"Ventech Capital II","source":"filing","n_filings":5,"first_seen":"2014-05-08","last_seen":"2017-03-21"}],"transactions":[{"id":4090822,"accession":"0001144204-17-015872","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-015872","line_url":"/filing/0001144204-17-015872#line-1","is_derivative":false,"issuer_cik":"0001372514","issuer_name":"EYEGATE PHARMACEUTICALS INC","issuer_ticker":"EYEG","issuer_name_source":null,"issuer_url":"/issuer/0001372514","owner_cik":"0001604072","owner_name":"Ventech Capital II","owner_display_name":"Ventech Capital II","owner_url":"/insider/0001604072","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4419.0,"shares_display":"4,419","price_per_share":2.8026,"price_display":"2.80","price_state":"stated","total_value":12384.6894,"total_display":"12,384.69","total_whole":"12,385","shares_owned_after":1431814.0,"shares_owned_after_display":"1,431,814","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-13","filed_date":"2017-03-21","scope":"insider"},{"id":2333288,"accession":"0001144204-16-107882","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-16-107882","line_url":"/filing/0001144204-16-107882#line-2","is_derivative":false,"issuer_cik":"0001372514","issuer_name":"EYEGATE PHARMACEUTICALS INC","issuer_ticker":"EYEG","issuer_name_source":null,"issuer_url":"/issuer/0001372514","owner_cik":"0001604072","owner_name":"Ventech Capital II","owner_display_name":"Ventech Capital II","owner_url":"/insider/0001604072","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15433.0,"shares_display":"15,433","price_per_share":3.0022,"price_display":"3.00","price_state":"stated","total_value":46332.9526,"total_display":"46,332.95","total_whole":"46,333","shares_owned_after":1593540.0,"shares_owned_after_display":"1,593,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-10","filed_date":"2016-06-10","scope":"insider"},{"id":2333282,"accession":"0001144204-16-107882","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-107882","line_url":"/filing/0001144204-16-107882#line-1","is_derivative":false,"issuer_cik":"0001372514","issuer_name":"EYEGATE PHARMACEUTICALS INC","issuer_ticker":"EYEG","issuer_name_source":null,"issuer_url":"/issuer/0001372514","owner_cik":"0001604072","owner_name":"Ventech Capital II","owner_display_name":"Ventech Capital II","owner_url":"/insider/0001604072","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13167.0,"shares_display":"13,167","price_per_share":3.0776,"price_display":"3.08","price_state":"stated","total_value":40522.7592,"total_display":"40,522.76","total_whole":"40,523","shares_owned_after":1608973.0,"shares_owned_after_display":"1,608,973","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-09","filed_date":"2016-06-10","scope":"insider"},{"id":3093716,"accession":"0001144204-16-107705","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-16-107705","line_url":"/filing/0001144204-16-107705#line-3","is_derivative":false,"issuer_cik":"0001372514","issuer_name":"EYEGATE PHARMACEUTICALS INC","issuer_ticker":"EYEG","issuer_name_source":null,"issuer_url":"/issuer/0001372514","owner_cik":"0001604072","owner_name":"Ventech Capital II","owner_display_name":"Ventech Capital II","owner_url":"/insider/0001604072","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":3.2,"price_display":"3.20","price_state":"stated","total_value":7680.0,"total_display":"7,680.00","total_whole":"7,680","shares_owned_after":1622140.0,"shares_owned_after_display":"1,622,140","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-08","filed_date":"2016-06-09","scope":"insider"},{"id":3093712,"accession":"0001144204-16-107705","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-16-107705","line_url":"/filing/0001144204-16-107705#line-2","is_derivative":false,"issuer_cik":"0001372514","issuer_name":"EYEGATE PHARMACEUTICALS INC","issuer_ticker":"EYEG","issuer_name_source":null,"issuer_url":"/issuer/0001372514","owner_cik":"0001604072","owner_name":"Ventech Capital II","owner_display_name":"Ventech Capital II","owner_url":"/insider/0001604072","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17000.0,"shares_display":"17,000","price_per_share":3.2388,"price_display":"3.24","price_state":"stated","total_value":55059.6,"total_display":"55,059.60","total_whole":"55,060","shares_owned_after":1624540.0,"shares_owned_after_display":"1,624,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-07","filed_date":"2016-06-09","scope":"insider"},{"id":3093708,"accession":"0001144204-16-107705","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-107705","line_url":"/filing/0001144204-16-107705#line-1","is_derivative":false,"issuer_cik":"0001372514","issuer_name":"EYEGATE PHARMACEUTICALS INC","issuer_ticker":"EYEG","issuer_name_source":null,"issuer_url":"/issuer/0001372514","owner_cik":"0001604072","owner_name":"Ventech Capital II","owner_display_name":"Ventech Capital II","owner_url":"/insider/0001604072","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":3.2684,"price_display":"3.27","price_state":"stated","total_value":32684.0,"total_display":"32,684.00","total_whole":"32,684","shares_owned_after":1641540.0,"shares_owned_after_display":"1,641,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-06","filed_date":"2016-06-09","scope":"insider"},{"id":8810002,"accession":"0001144204-15-011504","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001144204-15-011504","line_url":"/filing/0001144204-15-011504#line-5","is_derivative":false,"issuer_cik":"0001372514","issuer_name":"EYEGATE PHARMACEUTICALS INC","issuer_ticker":"EYEG","issuer_name_source":null,"issuer_url":"/issuer/0001372514","owner_cik":"0001604072","owner_name":"Ventech Capital II","owner_display_name":"Ventech Capital II","owner_url":"/insider/0001604072","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":102777.0,"shares_display":"102,777","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":616662.0,"total_display":"616,662.00","total_whole":"616,662","shares_owned_after":1494233.0,"shares_owned_after_display":"1,494,233","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-19","filed_date":"2015-02-23","scope":"insider"},{"id":7093336,"accession":"0001209191-14-032426","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-14-032426","line_url":"/filing/0001209191-14-032426#line-5","is_derivative":false,"issuer_cik":"0001178253","issuer_name":"SCYNEXIS INC","issuer_ticker":"SCYX","issuer_name_source":null,"issuer_url":"/issuer/0001178253","owner_cik":"0001604072","owner_name":"Ventech Capital II","owner_display_name":"Ventech Capital II","owner_url":"/insider/0001604072","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":28000.0,"shares_display":"28,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":280000.0,"total_display":"280,000.00","total_whole":"280,000","shares_owned_after":414211.0,"shares_owned_after_display":"414,211","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-07","filed_date":"2014-05-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001372514","name":"EYEGATE PHARMACEUTICALS INC","url":"/issuer/0001372514","role":"Ten percent owner","n_filings":4,"first_seen":"2015-02-23","last_seen":"2017-03-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001178253","name":"SCYNEXIS INC","url":"/issuer/0001178253","role":"Ten percent owner","n_filings":1,"first_seen":"2014-05-08","last_seen":"2014-05-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001604072","retrieved_at":"2026-08-22T13:00:51+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}